Placebo Gel: Clinical Trials

165 trials of Placebo Gel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

120 completed, 11 unknown, 10 recruiting, 7 terminated. 59 Phase 2, 48 Phase 3, 36 Not applicable, 24 Phase 1, 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 259Completed 38, Recruiting 5, Unknown 5, Withdrawn 4, Active not recruiting 3, Terminated 3, Suspended 1
Phase 348Completed 41, Unknown 3, Terminated 2, Recruiting 1, Withdrawn 1
Not applicable36Completed 21, Not yet recruiting 4, Recruiting 3, Unknown 3, Enrolling by invitation 2, Terminated 2, Active not recruiting 1
Phase 124Completed 23, Unknown 1
Phase 414Completed 13, Withdrawn 1
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow Placebo Gel: new trials by email Literature Review of Placebo Gel trials Research Report on Placebo Gel

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Evaluation of the Anti-Plaque and Anti-Gingivitis Effects of Nanobiofusion Gingival Gel (NBF), Placebo Gel, and Commercial Toothpaste
Nano Bio-Fusion (NBF) Gingival Gel, Placebo Gel, Commercial fluoride toothpaste - Gingivitis, Healthy Adult
Not applicableNot yet recruitingKing Abdullah University Hospital452026-10-012026-10-19
Locally Delivered Melatonin Gel in Management of Stage II Grade B Periodontitis
2% Melatonin gel, Placebo Gel - Periodontal Diseases
Not applicableNot yet recruitingAlexandria University232026-09-102026-09-10
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Geniwa gel, Placebo gel - HPV (Human Papillomavirus)-Associated, Genital Warts
Phase 2RecruitingKTH Biopharma702026-07-162026-10-20
Adjunctive Subgingival Pomegranate Peel Extract Gel for Stage II-III Periodontitis
Pomegranate Peel Extract Gel, Placebo gel - Periodontitis
Not applicableRecruitinggehad samy322026-07-012026-07-24
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
OCF001 Intravaginal Gel, Placebo Gel - Candidiasis, Vulvovaginal
Phase 2RecruitingSano Chemicals Inc362026-06-042026-06-15
Effectiveness and Safety of a Hydrating Gel Containing Polyvinyl Pyrrolidine, Algin and Hyaluronic Acid Applied After and Without Fractional CO₂ Laser Therapy
CO2 Fractional Laser, Hydrogel, Placebo gel - Hydration, Carbon-dioxide Laser
Not applicableNot yet recruitingDr.dr.Irma Bernadette, SpKK (K)512026-06-012026-06-10
FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL
YASO GEL, Placebo gel - Early-phase Safety and PK Study of a Vaginal Gel
Early Phase 1Not yet recruitingYaso Therapeutics Corporation722026-04-012025-12-19
Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
VMD-3866 Gel, Placebo Gel - Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain
Phase 2RecruitingVM Therapeutics LLC162025-12-122026-10-21
COMPASS - COpenhagen MenoPAuSe Study
Triptorelin 11.25 mg, Sodium Chloride 0.9%, Estradiol (E2) - Menopausal Osteoporosis, Bone Markers
Phase 2RecruitingMartin Blomberg Jensen1922025-10-022026-03-02
Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)
Probiotic/Prebiotic Supplement, Placebo Gel - Diabete Type 1
Not applicableNot yet recruitingUniversidad Católica San Antonio de Murcia802025-09-012025-07-14
Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris
Dapsone 7.5% gel, Vehicle gel - Acne Vulgaris
Phase 4CompletedOya Helin Dundar1002025-06-172026-05-22
Topical Chlorhexidine and Metronidazole Gels for Gingival Inflammation
Chlorhexidine Gluconate Gel 1%, Chlorhexidine Gluconate 0.5% + Metronidazole 1.5% Gel, Placebo Gel - Plaque Induced Gingivitis
Not applicableCompletedH.P. Government Dental College and Hospital Shimla1202025-05-162026-08-21
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 4CompletedIstanbul Training and Research Hospital452025-05-012026-02-24
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
ARC-001, Placebo gel - Acute Post Operative Pain, Third Molar Extraction Surgery
Early Phase 1RecruitingArcato Laboratories, Inc.302025-02-262025-03-11
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
AMZ001 Diclofenac gel, Placebo gel - Osteoarthritis of Knee, Osteoarthritis, Knee
Phase 3CompletedAmzell5492025-02-182026-07-15
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
Diclofenac Sodium Gel, Placebo gel - Head and Neck Tumor, Breast Cancer
Not applicableRecruitingThe Second Affiliated Hospital of Hainan Medical University1562025-02-132026-04-03
A Clinical Trial to Compare the Photoprotective Effects of Cucumber Seed Extract vs Placebo in Filipino Adults by Measurement of Minimal Erythema Dose
Placebo gel, 2% cucumber seed gel, 4% cucumber seed gel - Healthy Human Volunteers With Fitzpatrick Skin Type III-V, Sunburn, Erythema
Not applicableCompletedDOH - Tondo Medical Center292025-01-272026-07-31
Palatal Mucosa Wound Healing Following Antimicrobial Gel Application
Gel containing postbiotics, lactoferrin, aloe barbadensis leaf juice powder and sodium hyaluronate, Placebo gel - Wound Healing, Palate; Wound
Not applicableActive not recruitingUniversity of Roma La Sapienza132024-12-222025-04-23
Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis
Placebo gel, Enamel Matrix Proteins Derivative - Mucositis, Peri Implant Mucositis
Not applicableEnrolling by invitationUniversity of Catania542024-12-052025-06-04
"Comparison of Spirulina Gels for Treating Stage II Grade B Periodontitis"
Placebo gel, Spirulina Gel, Spirulina Nanoparticles Gel - Periodontitis Stage II
Not applicableEnrolling by invitationKafrelsheikh University152024-10-212025-02-11

Showing 20 of 165. Sign in to see all of them.

Conditions studied

Pain (11)  ·  Hypogonadism (9)  ·  Chronic Periodontitis (8)  ·  Dentin Sensitivity (6)  ·  HIV Infections (6)  ·  Periodontitis (5)  ·  Wounds and Injuries (5)  ·  Inflammation (4)  ·  Keratosis, Actinic (4)  ·  Osteoarthritis, Knee (4)  ·  Periodontal Diseases (4)  ·  Rosacea (4)  ·  Sexual Dysfunctions, Psychological (4)  ·  Vaginosis, Bacterial (4)  ·  Acne Vulgaris (3)

Sponsors

Government Dental College and Research Institute, Bangalore (6)  ·  Starpharma Pty Ltd (5)  ·  BioSante Pharmaceuticals (4)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (4)  ·  Padagis LLC (4)  ·  University of Washington (4)  ·  Bayer (3)  ·  Kafrelsheikh University (3)  ·  Olatec Therapeutics, Inc. (3)  ·  Universidade Federal do Para (3)  ·  University of Colorado, Denver (3)  ·  AbbVie (prior sponsor, Abbott) (2)  ·  Alexandria University (2)  ·  Assiut University (2)  ·  Behar, Caren, M.D. (2)

Countries

United States (69)  ·  Egypt (12)  ·  Germany (9)  ·  Brazil (8)  ·  Canada (8)  ·  Italy (7)  ·  India (6)  ·  China (4)  ·  United Kingdom (4)  ·  Czechia (3)  ·  Denmark (3)  ·  Taiwan (3)  ·  Turkey (Türkiye) (3)  ·  Ukraine (3)  ·  Dominican Republic (2)

Top investigators

Michael C Snabes, MD, PhD (4)  ·  Caren Behar, MD (2)  ·  Janet Benesh (2)  ·  Jeremy Paull, PhD. (2)  ·  Stephanie T Page, MD, PhD (2)  ·  A R Pradeep, M.D.S. (1)  ·  Alexa Kimball, MD, MPH (1)  ·  Amira R AL-Agooz (1)  ·  Amy Degnim, M.D. (1)  ·  Andrea Scribante, DDS, PhD (1)  ·  Andrea Z LaCroix, PhD (1)  ·  Andrew Combs, MD (1)  ·  Anna Wald, MD, MPH (1)

Results publications

PMID 24361112, PMID 25962554, PMID 31779508, PMID 38224135, PMID 15215482, PMID 17453597, PMID 19186342, PMID 20368766, PMID 21177791, PMID 21330907, PMID 21505316, PMID 22172433, PMID 22395584, PMID 22683276, PMID 22760426, PMID 23000649, PMID 23093256, PMID 23165659, PMID 23218853, PMID 23334506, PMID 23494931, PMID 23839181, PMID 23964752, PMID 24012096, PMID 24106072, PMID 24486592, PMID 24898857, PMID 26044291, PMID 26265463, PMID 26950683, PMID 27172434, PMID 27783532, PMID 28404609, PMID 28731373, PMID 28870177, PMID 29554173, PMID 29738424, PMID 29800026, PMID 30297352, PMID 30410934, PMID 30994576, PMID 314790, PMID 32250330, PMID 32542985, PMID 32940653, PMID 32996096, PMID 33251157, PMID 33367735, PMID 33539256, PMID 33675793

NIH funding

2014 (1), 2015 (1), 2016 (1), 2019 (1), 2025 (1), K23AG027238 (1), K23NS070337 (1), N01CN35157 (1), P30CA060553 (1), R01AG027156 (1), R01AG037603 (1), R01AG049762 (1), R01CA237607 (1), R01HD047722 (1), R44HD118927 (1)